Short-Term Exposure for PTSD



Status:Recruiting
Conditions:Psychiatric, Psychiatric, Psychiatric
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:18 - 65
Updated:3/30/2019
Start Date:June 2016
End Date:March 31, 2020
Contact:Michele A Bedard-Gilligan, PhD
Email:uwstep@uw.edu
Phone:2066853617

Use our guide to learn which trials are right for you!

Marijuana Use, Extinction Learning, and Exposure Therapy in Individuals With PTSD

This study examines how marijuana use affects processes related to recovery from chronic
posttraumatic stress disorder (PTSD). Half the participants will be individuals with chronic
PTSD and heavy marijuana use and half will be individuals with chronic PTSD and no marijuana
use. This study will assess how individuals with PTSD with heavy or no marijuana use perform
on a discriminative conditioning and extinction paradigm designed to measure fear extinction
learning, and how they respond to a brief daily imaginal exposure treatment in regards to
PTSD symptom reduction.

In this study, 36 patients with chronic PTSD and heavy marijuana use (heavy) and 36 patients
with chronic PTSD and no marijuana use (no use) will be recruited to examine the effects of
marijuana use on behavioral (emotional experiencing), physiological (skin conductance,
acoustic startle) and biological (cortisol, blood pressure) responding on a well-established
discriminative conditioning and extinction paradigm. To examine real world therapeutic
implications, we will also examine how individuals with PTSD and heavy or no marijuana use
differentially respond to a brief (6 session, 50 min) daily imaginal exposure (IE) treatment.
Throughout treatment, we will monitor level of cannabis metabolites in urine samples of
marijuana users to correlate effects to outcomes and preliminarily explore how varying levels
of cannabis metabolites affect extinction processes. Independent evaluators will assess
patients at baseline, 4 weeks, and 12 weeks following study entry.

Inclusion Criteria:

1. Current PTSD diagnosis based on DSM-5 criteria, with a minimum duration of 12 weeks
since the traumatic event;

2. Between the age of 18 and 65;

3. Current heavy marijuana use (5+ days per week for 3+ months) or no marijuana use in
the last 3 months

4. Current diagnosis of a cannabis use disorder based on DSM-5 or no current diagnosis of
a substance use disorder

Exclusion Criteria:

1. Current diagnosis of schizophrenia, delusional disorder, or organic mental disorder as
defined by the DSM-5.

2. Current diagnosis of bipolar disorder, depression with psychotic features, or
depression severe enough to require immediate psychiatric treatment (i.e., serious
suicide risk with intent and plan).

3. Unwilling or unable to discontinue current trauma-focused psychotherapy

4. Any previous experience with prolonged exposure (PE) treatment

5. No clear trauma memory or trauma before age 3

6. Unstable dose of psychotropic medications in the prior 3 months

7. Ongoing intimate relationship with the perpetrator (in assault related PTSD cases).

8. Current diagnosis of a substance use disorder according to DSM-5, other than marijuana
in the last 3 months.
We found this trial at
1
site
Seattle, Washington 98104
(206) 543-2100
Principal Investigator: Michele A Bedard-Gilligan, PhD
Phone: 206-685-3617
Univ of Washington Founded in 1861 by a private gift of 10 acres in what...
?
mi
from
Seattle, WA
Click here to add this to my saved trials